Device saturation
Is Morpheus8 Saturated in Alabama?
Ask Paige tracks 15 practices running Morpheus8 in Alabama, averaging 4.8★ on Google — about 4.0% of all tracked practices statewide. Compiled from proprietary intelligence gathered by Fathom's collection engine, not manufacturer install figures.
Alabama runs Morpheus8 at a lower rate than the national average — there's more room to differentiate here than in a typical market.
FDA clearance
510(k) K231790 — InMode , Ltd.. Cleared for: General, Plastic Surgery; Summary.
Treatments paired with Morpheus8 in Alabama
| Name | Count | Percent | You offer |
|---|---|---|---|
| Body Contouring | 12 | 80% | no |
| Laser Hair Removal | 12 | 80% | no |
| Dermal Filler | 11 | 73.3% | no |
| Chemical Peel | 11 | 73.3% | no |
| RF Microneedling | 10 | 66.7% | no |
| Botox / Neurotoxin | 10 | 66.7% | no |
| Skin Tightening | 6 | 40% | no |
| Weight Loss / GLP-1 | 5 | 33.3% | no |
| Porcelain Veneers | 4 | 26.7% | no |
| PRP / PRF | 3 | 20% | no |
Frequently asked
How many practices in Alabama have Morpheus8?
Ask Paige tracks 15 practices running Morpheus8 in Alabama, about 4.0% of all tracked practices in the state.
Is Morpheus8 saturated in Alabama?
Alabama runs Morpheus8 at a lower rate than the national average — there's more room to differentiate here than in a typical market.
Does Morpheus8 have FDA clearance?
FDA 510(k) K231790, cleared for InMode , Ltd.. Cleared indications: General, Plastic Surgery; Summary.
What treatments is Morpheus8 typically used for?
In Ask Paige's corpus, practices running Morpheus8 most often pair it with: RF Microneedling.
See if Morpheus8 pencils out for your practice in Alabama.
See how your practice compares against Ask Paige's proprietary practice intelligence — devices, services, ratings, and demand, side by side with yours.
Start free trial30-day pilot, the Rep-Meeting Test (card required to start; no charge if you cancel within 30 days), then $99/month founding rate for the first 100 practices or $199/month standard rate. Cancel anytime.